Carl Russo - 30 Jan 2023 Form 4 Insider Report for CALIX, INC (CALX)

Role
Director, 10%+ Owner
Signature
/s/ Tom Gemetti as Attorney-in-Fact for Carl Russo.
Issuer symbol
CALX
Transactions as of
30 Jan 2023
Net transactions value
+$1,682,000
Form type
4
Filing time
30 Jan 2023, 17:56:19 UTC
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALX Common Stock Options Exercise $1,682,000 +200,000 +5.8% $8.41* 3,628,381 30 Jan 2023 Direct
holding CALX Common Stock 2,239,188 30 Jan 2023 See Footnote F1
holding CALX Common Stock 284,653 30 Jan 2023 See Footnote F2
holding CALX Common Stock 275,633 30 Jan 2023 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CALX Stock Option (right to buy) Options Exercise $0 -200,000 -100% $0.000000* 0 30 Jan 2023 Common Stock 200,000 $8.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by The Crescentico Trust, Carl Russo, Trustee.
F2 Shares held by Calgrat Partners, L.P. The managing partner of Calgrat Partners, L.P. is Tim Pasquinelli. Carl Russo and Tim Pasquinelli may be deemed to have shared voting and investment power over the shares held by Calgrat Partners, L.P. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F3 Shares held by Equanimous Investments. The managing members of Equanimous Investments are Carl Russo and Tim Pasquinelli. These individuals may be deemed to have shared voting and investment power over the shares held by Equanimous Investments. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F4 100% of the shares subject to the option were fully vested and exercisable on February 21, 2017.